GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » EBITDA Margin %

Innovita Biological Technology Co (SHSE:688253) EBITDA Margin % : 53.99% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovita Biological Technology Co's EBITDA for the three months ended in Mar. 2025 was ¥111.7 Mil. Innovita Biological Technology Co's Revenue for the three months ended in Mar. 2025 was ¥207.0 Mil. Therefore, Innovita Biological Technology Co's EBITDA margin for the quarter that ended in Mar. 2025 was 53.99%.


Innovita Biological Technology Co EBITDA Margin % Historical Data

The historical data trend for Innovita Biological Technology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co EBITDA Margin % Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial 65.58 46.24 41.19 46.86 48.02

Innovita Biological Technology Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.54 47.77 43.48 -6.60 53.99

Competitive Comparison of Innovita Biological Technology Co's EBITDA Margin %

For the Biotechnology subindustry, Innovita Biological Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovita Biological Technology Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovita Biological Technology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innovita Biological Technology Co's EBITDA Margin % falls into.


;
;

Innovita Biological Technology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innovita Biological Technology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=298.422/621.389
=48.02 %

Innovita Biological Technology Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=111.739/206.966
=53.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovita Biological Technology Co  (SHSE:688253) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Innovita Biological Technology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines